OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities
Lisa K. Stamp, Hamish Farquhar, Huai Leng Pisaniello, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 633-641
Open Access | Times Cited: 60
Lisa K. Stamp, Hamish Farquhar, Huai Leng Pisaniello, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 633-641
Open Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
Mechanisms and rationale for uricase use in patients with gout
Naomi Schlesinger, Fernando Perez‐Ruiz, Frédéric Lioté
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 10, pp. 640-649
Closed Access | Times Cited: 46
Naomi Schlesinger, Fernando Perez‐Ruiz, Frédéric Lioté
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 10, pp. 640-649
Closed Access | Times Cited: 46
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
Sankar D. Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, et al.
American Journal of Kidney Diseases (2024)
Closed Access | Times Cited: 17
Sankar D. Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, et al.
American Journal of Kidney Diseases (2024)
Closed Access | Times Cited: 17
Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products
Ling Dong, Fengying Dong, Pingping Guo, et al.
Phytomedicine (2025) Vol. 138, pp. 156402-156402
Closed Access | Times Cited: 8
Ling Dong, Fengying Dong, Pingping Guo, et al.
Phytomedicine (2025) Vol. 138, pp. 156402-156402
Closed Access | Times Cited: 8
Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights
Yongsheng Mei, Bingzi Dong, Zhuang Geng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 67
Yongsheng Mei, Bingzi Dong, Zhuang Geng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 67
Impact of Hyper- and Hypo-Uricemia on Kidney Function
Junichiro Miake, Ichiro Hisatome, Katsuyuki Tomita, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1258-1258
Open Access | Times Cited: 25
Junichiro Miake, Ichiro Hisatome, Katsuyuki Tomita, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1258-1258
Open Access | Times Cited: 25
Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease
Da Young Lee, Jun Sung Moon, Inha Jung, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access | Times Cited: 1
Da Young Lee, Jun Sung Moon, Inha Jung, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access | Times Cited: 1
Update on gout management: what is old and what is new
Yuliya Afinogenova, Abhijeet Danve, Tuhina Neogi
Current Opinion in Rheumatology (2021) Vol. 34, Iss. 2, pp. 118-124
Open Access | Times Cited: 46
Yuliya Afinogenova, Abhijeet Danve, Tuhina Neogi
Current Opinion in Rheumatology (2021) Vol. 34, Iss. 2, pp. 118-124
Open Access | Times Cited: 46
Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications
Hans‐Joachim Anders, Qiubo Li, Stefanie Steiger
Clinical Kidney Journal (2023) Vol. 16, Iss. 6, pp. 928-938
Open Access | Times Cited: 20
Hans‐Joachim Anders, Qiubo Li, Stefanie Steiger
Clinical Kidney Journal (2023) Vol. 16, Iss. 6, pp. 928-938
Open Access | Times Cited: 20
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis
Yuxin Luo, Qirong Song, Jiaxiao Li, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Yuxin Luo, Qirong Song, Jiaxiao Li, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Protecting against ferroptosis in hyperuricemic nephropathy: The potential of ferrostatin-1 and its inhibitory effect on URAT1
Yongmei Li, Fengxin Zheng, Shiqi Zhong, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176528-176528
Closed Access | Times Cited: 7
Yongmei Li, Fengxin Zheng, Shiqi Zhong, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176528-176528
Closed Access | Times Cited: 7
Mechanism of Lacticaseibacillus rhamnosus JY027 alleviating hyperuricemia in mice through gut-kidney axis
Chao Miao, Kai Dong, Yu Shen, et al.
Food Bioscience (2024) Vol. 61, pp. 104757-104757
Closed Access | Times Cited: 7
Chao Miao, Kai Dong, Yu Shen, et al.
Food Bioscience (2024) Vol. 61, pp. 104757-104757
Closed Access | Times Cited: 7
A glance into the future of gout
Francisca Sivera, Mariano Andrés, Nicola Dalbeth
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 27
Francisca Sivera, Mariano Andrés, Nicola Dalbeth
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 27
Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom
Mark Russell, Andrew I Rutherford, Benjamin Ellis, et al.
The Lancet Regional Health - Europe (2022) Vol. 18, pp. 100416-100416
Open Access | Times Cited: 26
Mark Russell, Andrew I Rutherford, Benjamin Ellis, et al.
The Lancet Regional Health - Europe (2022) Vol. 18, pp. 100416-100416
Open Access | Times Cited: 26
Update on Uric Acid and the Kidney
Giana Kristy Ramos, David S. Goldfarb
Current Rheumatology Reports (2022) Vol. 24, Iss. 5, pp. 132-138
Closed Access | Times Cited: 25
Giana Kristy Ramos, David S. Goldfarb
Current Rheumatology Reports (2022) Vol. 24, Iss. 5, pp. 132-138
Closed Access | Times Cited: 25
Management of Patients with Gout and Kidney Disease: A Review of Available Therapies and Common Missteps
Vijay Kannuthurai, Angelo Gaffo
Kidney360 (2023) Vol. 4, Iss. 9, pp. e1332-e1340
Open Access | Times Cited: 14
Vijay Kannuthurai, Angelo Gaffo
Kidney360 (2023) Vol. 4, Iss. 9, pp. e1332-e1340
Open Access | Times Cited: 14
Uric acid en route to gout
Wei‐Zheng Zhang
Advances in clinical chemistry (2023), pp. 209-275
Closed Access | Times Cited: 12
Wei‐Zheng Zhang
Advances in clinical chemistry (2023), pp. 209-275
Closed Access | Times Cited: 12
The relationship of organophosphate flame retardants with hyperuricemia and gout via the inflammatory response: An integrated approach
Yuxuan Tan, Yingyin Fu, Huojie Yao, et al.
The Science of The Total Environment (2023) Vol. 908, pp. 168169-168169
Closed Access | Times Cited: 11
Yuxuan Tan, Yingyin Fu, Huojie Yao, et al.
The Science of The Total Environment (2023) Vol. 908, pp. 168169-168169
Closed Access | Times Cited: 11
Monitoring and Management of Uric Acid Therapy in Gout and Chronic Kidney Disease: A Single-Center Retrospective Study
Ioannis Karageorgiou, Zeeshan Javed, Austen Grooms, et al.
Cureus (2025)
Open Access
Ioannis Karageorgiou, Zeeshan Javed, Austen Grooms, et al.
Cureus (2025)
Open Access
Editorial: Community series in advances in pathogenesis and therapies of gout, volume II
Lihua Duan, Jixin Zhong, Yang Ye, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Lihua Duan, Jixin Zhong, Yang Ye, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Automated Discovery of Therapeutic Biomaterial for Renally Impaired Hyperuricemia Patients by Natural Language Processing and Machine Learning
Xiaodong Zeng, Jiahao Qiu, Xin Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Xiaodong Zeng, Jiahao Qiu, Xin Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review
Noha A Kamel, M. Stokes, Daniel F. B. Wright, et al.
Journal of Nephrology (2025)
Open Access
Noha A Kamel, M. Stokes, Daniel F. B. Wright, et al.
Journal of Nephrology (2025)
Open Access
Prolonged monitoring and risk management of hyperuricemia using interference-resistant wearable bioelectronics
Yue Hu, Yawen Yang, Hongwei Chu, et al.
Device (2025), pp. 100753-100753
Closed Access
Yue Hu, Yawen Yang, Hongwei Chu, et al.
Device (2025), pp. 100753-100753
Closed Access
Progress in oral biomaterials for the treatment of metabolic bone diseases
Yunkai Tang, Adilijiang Abudousu, Wenguo Cui
Progress in Materials Science (2025), pp. 101499-101499
Closed Access
Yunkai Tang, Adilijiang Abudousu, Wenguo Cui
Progress in Materials Science (2025), pp. 101499-101499
Closed Access
Management of gout in advanced renal disease
J. Steuart Richards, Namitha Nair, Ramkumar Mohan
Exploration of Musculoskeletal Diseases (2025) Vol. 3
Open Access
J. Steuart Richards, Namitha Nair, Ramkumar Mohan
Exploration of Musculoskeletal Diseases (2025) Vol. 3
Open Access
Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease
J. Bausson, Nicolas Keller, Jean‐Jacques Von Hunolstein, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003872-e003872
Open Access | Times Cited: 3
J. Bausson, Nicolas Keller, Jean‐Jacques Von Hunolstein, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003872-e003872
Open Access | Times Cited: 3
